Oman · Delayed Price · Currency is OMR Sage Therapeutics Statistics
Total Valuation
MSM:AACT has a market cap or net worth of OMR 40.26 million. The enterprise value is 44.13 million.
| Market Cap | 40.26M |
| Enterprise Value | 44.13M |
Important Dates
The last earnings date was Thursday, July 10, 2025.
| Earnings Date | Jul 10, 2025 |
| Ex-Dividend Date | Mar 25, 2025 |
Share Statistics
MSM:AACT has 220.00 million shares outstanding.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.03% |
| Float | 77.23M |
Valuation Ratios
The trailing PE ratio is 113.74 and the forward PE ratio is 14.64.
| PE Ratio | 113.74 |
| Forward PE | 14.64 |
| PS Ratio | 2.12 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 124.65 |
| EV / Sales | 2.33 |
| EV / EBITDA | 16.60 |
| EV / EBIT | 123.63 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 1.53 |
| Debt / FCF | n/a |
| Interest Coverage | 1.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 0.67% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MSM:AACT has paid 62,551 in taxes.
| Income Tax | 62,551 |
| Effective Tax Rate | 15.02% |
Stock Price Statistics
The stock price has increased by +4.00% in the last 52 weeks. The beta is 0.61, so MSM:AACT's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +4.00% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 56.69 |
| Average Volume (20 Days) | 506,996 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MSM:AACT had revenue of OMR 18.96 million and earned 354,018 in profits. Earnings per share was 0.00.
| Revenue | 18.96M |
| Gross Profit | 3.72M |
| Operating Income | 356,940 |
| Pretax Income | 416,569 |
| Net Income | 354,018 |
| EBITDA | 2.52M |
| EBIT | 356,940 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 203,700 in cash and 4.07 million in debt, giving a net cash position of -3.87 million or -0.02 per share.
| Cash & Cash Equivalents | 203,700 |
| Total Debt | 4.07M |
| Net Cash | -3.87M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 29.22M |
| Book Value Per Share | 0.13 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 19.63%, with operating and profit margins of 1.88% and 1.87%.
| Gross Margin | 19.63% |
| Operating Margin | 1.88% |
| Pretax Margin | 2.20% |
| Profit Margin | 1.87% |
| EBITDA Margin | 13.28% |
| EBIT Margin | 1.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 2.19%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 2.19% |
| Dividend Growth (YoY) | -80.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 2.20% |
| Earnings Yield | 0.88% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 27, 2021. It was a reverse split with a ratio of 0.742707084.
| Last Split Date | May 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.742707084 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |